1. A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma. Issue 7 (7th June 2021) Authors: Khan, Sahar; LeBlanc, Richard; Gyger, Martin; White, Darrell; Kaufman, Johnathan; Jazubowiak, Andrzej; Gul, Engin; Paul, Harminder; Le, Lisa W.; Lau, Anthea; Li, Zhihua; Trudel, Suzanne Journal: Leukemia & lymphoma Issue: Volume 62:Issue 7(2021) Page Start: 1721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗